Lv2
138 积分 2026-06-04 加入
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
5天前
已完结
The pathobiology and treatment of mucus plugs in asthma and COPD: state of the art
16天前
已完结
From data to decision: critical appraisal of the 2025 NeuPSIG review and recommendations on neuropathic pain treatments
17天前
已完结
TSLP and TSLPr Expression and Localization in the Airways of COPD and Non‐COPD Patients
19天前
已完结
Developing and Validation of a Multimodal-Based Machine Learning Model for Diagnosis of Usual Interstitial Pneumonia
23天前
已完结
TSLP and TSLPr Expression and Localization in the Airways of COPD and Non‐COPD Patients
26天前
已完结
Blood-based biomarkers of Alzheimer’s disease—A guideline for clinical use
1个月前
已完结
Efficacy of multi-cycle Efgartigimod in achieving minimal symptom expression in myasthenia gravis: A comparative multi-center study
1个月前
已完结
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
